# A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS

> **NCT00001058** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 246 (—)

## Conditions studied

- Mycobacterium Avium-intracellulare Infection
- HIV Infections

## Interventions

- **DRUG:** Indinavir sulfate
- **DRUG:** Ritonavir
- **DRUG:** Ethambutol hydrochloride
- **DRUG:** Clarithromycin
- **DRUG:** Rifabutin

## Key facts

- **NCT ID:** NCT00001058
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1999-01
- **Target enrollment:** 246 (—)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001058, "A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00001058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*